共 169 条
[1]
Fleisch H(1993)New bisphosphonates in osteoporosis Osteoporos Int 3 15-22
[2]
O’Doherty DP(1990)Treatment of Paget’s disease of bone with aminohydroxybutylidene bisphosphonate J Bone Miner Res 5 483-91
[3]
Bickerstaff DR(1993)Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia J Clin Oncol 11 1618-23
[4]
McCloskey EV(1987)The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy Bone Miner 2 395-404
[5]
Nussbaum SR(1995)Rationale for the use of alendronate in osteoporosis Osteoporos Int 5 1-13
[6]
Warrell JRP(1993)Preclinical pharmacology of alendronate Osteoporos Int 3 7-12
[7]
Rude R(1991)Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease Drugs 42 919-44
[8]
Adami S(1991)Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure J Clin Invest 88 2095-105
[9]
Bolzicco GP(1995)Acid extrusion is induced by osteoclast attachment to bone: inhibition by alendronate and calcitonin J Clin Invest 96 2277-83
[10]
Rizzo A(1990)Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy J Bone Miner Res 5 31-40